Turku University hospital
Turku, 20521, Finland
Location status: Recruiting
NCT Number: NCT06138080
The purpose of this study is to examine the applicability of contrast enhanced voiding ultrasonography in diagnosing vesicoureteral reflux (VUR) in pediatric patients compared to direct isotope cystography. The aim of the study is to find a modality allowing the accurate diagnosis of VUR and the classification of the degree of VUR with the least possible harm from the examinations.
The investigators recruit 100 under 6 years old patients who have had at least 2 culture positive urinary tract infections. Exluding criteria are abnormal bladder function and posterior uretral valves. The investigators perform direct isotope cystography and contrast enhanced voiding urosonography during the same day to diagnose and grade VUR. The investigators use standardized volume and speed of bladder filling. The examinations are done by a radiologist and an isotope specialist and they are blinded to the result of the other examination.
Interested in participating?
Request Info0 year–6 year
All sexes
Interventional
Not applicable
Turku, 20521, Finland
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
We have no specific intervention. We investigate different diagnostic modalities of VUR.
Time frame: 1 day
The primary outcome measure of this study is the diagnostic accoracy of CEVUS in detecting vesicoureteral reflux compared to direct isotope cystography, expressed as the sensitivity and specificity of each method
Time frame: 1 year
The secondary outcome measure of this study is the incidence and severity of adverse effects associated with CEVUS as compared to direct isotope cystography.
Contact information is provided by the study sponsor or research team.
Hanna-Reeta Viljamaa
CONTACT
Niklas Pakkasjärvi
CONTACT
Turku University Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06349668
Benign Neoplasm of Ureter, Benign Renal Neoplasm
Kalmar, Sweden
View Trial DetailsNCT03653702
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Boston, Massachusetts, United States
View Trial DetailsNCT07334821
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Istanbul, Pendik, Turkey (Türkiye)
View Trial DetailsNCT05864131
Agnosia, Female Urogenital Diseases
Seoul, South Korea
View Trial Details